Skip to main content

Table 3 BRCA promoter methylation percentages in BRCA1/2-related and sporadic breast carcinomas by methylation-specific multiplex ligation-dependent probe amplification

From: BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers

Probe

BRCA1C-C, median % (range)

BRCA2-C, median % (range)

Sporadic-C, median % (range)

Test statistica

p Value

BRCA1.1

3 (0–11)

3 (0–91)

3 (0–80)

2494.500

0.140

BRCA1.2

21 (11–34)

17 (11–100)

15 (9–85)

1795.500

0.00006*

BRCA1.3

11 (5–18)

9 (5–100)

7 (3–71)

1760.600

0.00003*

BRCA2.1

24 (14–56)

21 (8–100)

15 (8–43)

947.500

9.85°10−13*

BRCA2.2

11 (5–27)

10 (5–100)

5 (3–15)

596.000

1.00°10−13*

BRCA2.3

17 (9–33)

14 (8–100)

9 (5–18)

536.500

1.00°10−13*

BRCA2.4

9 (0–18)

8 (0–100)

5 (2–12)

984.500

1.95°10−12*

  1. Abbreviations: BRCA1-C Breast carcinomas from BRCA1 germline mutation carriers, BRCA2-C Breast carcinomas from BRCA2 germline mutation carriers, Sporadic-C Sporadic breast carcinoma
  2. aMann-Whitney U test for BRCA1-C and BRCA2-C together against Sporadic-C
  3. *Statistically significant (two-sided p value <0.05)